Table 4 Subgroup meta-analysis results based on study design
| Â | Number of studies | Number of participants | Ln DOR (95%CI) | SE | P-value* | I2(%) | T | T2 (SE) | Cochran's Q (P-value) |
|---|---|---|---|---|---|---|---|---|---|
Poor response | |||||||||
 Cohort | |||||||||
  AMH | 15 | 17772 | 2.60 (2.01, 3.20) | 0.30 | < 0.0001 | 93.86 | 1.07 | 1.14 (0.51) | 128.55 (< 0.0001) |
  AFC | 10 | 14240 | 2.61 (1.86, 3.35) | 0.37 | < 0.0001 | 74.65 | 0.75 | 0.57 (0.53) | 18.05 (0.00) |
  FSH | 5 | 3315 | 1.40 (0.52, 2.28) | 0.44 | <0.0001 | 77.22 | 0.82 | 0.68 (0.70) | 13.95 (0.00) |
  E2 | 2 | 290 | 0.56 (-1.57, 2.70) | 1.09 | 0.60 | 72.67 | 1.34 | 1.81 (3.52) | 3.65 (0.05) |
Cross Sectional | |||||||||
  AMH | 5 | 723 | 1.99 (0.88, 3.10) | 0.56 | 0.0004 | 86.20 | 1.15 | 1.33 (1.13) | 35.06 (< 0.0001) |
  AFC | 4 | 584 | 1.01 (0.59, 1.44) | 0.21 | <0.0001 | 0.00 | 0 | 0 (0.14) | 0.01 (0.99) |
  FSH | 4 | 679 | 0.71 (0.34, 1.08) | 0.19 | 0.0002 | 0.00 | 0 | 0 (0.11) | 2.91 (0.40) |
High response | |||||||||
 Cohort | |||||||||
  AMH | 11 | 8639 | 2.40 (1.84, 2.96) | 0.28 | < 0.0001 | 93.02 | 0.84 | 0.70 (0.39) | 64.75 (< 0.0001) |
  AFC | 7 | 4083 | 2.71 (1.32, 4.09) | 0.70 | < 0.0001 | 94.53 | 1.65 | 2.74 (1.89) | 39.61 (< 0.0001) |
  FSH | 3 | 3112 | 0.89 (-0.25, 2.04) | 0.585 | 0.1262 | 73.05 | 0.86 | 0.74 (1.02) | 7.30 (0.02) |
Cross Sectional | |||||||||
  AMH | 2 | 401 | 3.24 (1.57, 4.92) | 0.85 | 0.00 | 60.99 | 0.99 | 0.98 (2.28) | 2.56 (0.10) |
  FSH | 2 | 235 | 1.86 (-1.02, 4.75) | 1.47 | 0.20 | 93.92 | 2.02 | 4.08 (6.15) | 16.4567 (< 0.0001) |